Two Sigma Advisers’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01M | Sell |
470,000
-179,800
| -28% | -$1.15M | 0.01% | 938 |
|
|
2025
Q1 | $2.3M | Buy |
649,800
+408,400
| +169% | +$1.45M | 0.01% | 1102 |
|
|
2024
Q4 | $912K | Sell |
241,400
-68,100
| -22% | -$257K | ﹤0.01% | 1508 |
|
|
2024
Q3 | $1M | Sell |
309,500
-844,700
| -73% | -$2.74M | ﹤0.01% | 1413 |
|
|
2024
Q2 | $2.19M | Buy |
1,154,200
+355,300
| +44% | +$675K | ﹤0.01% | 1142 |
|
|
2024
Q1 | $2.27M | Buy |
+798,900
| New | +$2.27M | 0.01% | 1152 |
|